There is no definitive human research establishing which schedule is optimal
All research activities should follow applicable laboratory safety standards and institutional guidelines
Protocol : BPC-157: 500 mcg/day (near injury or systemic) CJC-1295 w/ DAC: 2 mg twice per week Ipamorelin: 100200 mcg, 12x/day Duration: 68 weeks max Stacking Summary Potential Side Effects and Safety Profile of BPC-157 Compared to most performance-enhancing drugs, peptides, or even over-the-counter recovery aids, BPC-157 is remarkably well-tolerated
Recently, scientists have developed a protocol that can generate pancreatic beta cells
According to a 2020 review, sermorelin can double growth hormone levels for up to 12 hours after injection, with levels peaking around the two-hour mark (1)
BPC-157 is supplied strictly for laboratory research use only